Delivery Order SPE2DB20D1004-SPE2DB24FF7L6

Award Date 4/3/24
Potential Completion Date 4/4/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,514.28 firm fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,674.74 firm fixed-price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a cardiovascular medication. The award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,037.76 firm-fixed-price delivery order covers the supply of Micardis HCT 40-12.5 mg tablets, a cardiovascular medication, with a completion date of September 23, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,234.73 firm fixed price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a $11,379.77 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Micardis HCT 80-12.5 mg tablets. This order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does...
The federal contract award, valued at $2,654.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract with a firm fixed price, and it covers the supply of Micardis HCT 40-12.5 mg tablets for the ultimate completion date of January 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.14 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,172.44 delivery order is for the supply of Micardis HCT 80-25 mg tablets, a cardiovascular medication. The contract is a firm fixed-price, no set-aside delivery order that is part of a larger $999,999,999 Indefinite Delivery Contract held by AmerisourceBergen with the DLA Troop Support Medical division. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,383.26 firm fixed-price delivery order is for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S, a cardiovascular medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 through November 2026. The IDC serves as a comprehensive procurement...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,040.77 firm fixed-price delivery order is for the supply of Micardis HCT 80-12.5 mg tablets, a hypertension medication, to support military treatment programs and facilities. The award is not a set-aside contract. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF7L6
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,592.04 firm fixed price delivery order is for the supply of Micardis HCT 40-12.5 mg tablets. This award is a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA IDC, Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 11:09 AM